UK drug availability in Parkinson's

Thank you for helping us. We are interested in ways of speeding new drugs to patients. But in order to do so, it would be helpful to know what people understand about the current regulatory process to new medicines. The survey has 12 questions and is OPEN TO PEOPLE LIVING IN THE UK ONLY (different regulatory processes apply in other countries). The survey should only take around 10 to 15 minutes. Thank you for your time.

Question Title

* 1. For a drug to be a licensed medication for Parkinson’s the drug must have:
TICK ALL THAT APPLY

Question Title

* 2. How long does any testing typically need to be? TICK ONE ANSWER
Animal tests must be:

Question Title

* 3. How long does any testing typically need to be?  TICK ONE ANSWER
Tests in healthy humans must be:

Question Title

* 4. How long does any testing typically need to be? TICK ONE ANSWER
Tests in Parkinson's patients must be:

Question Title

* 5. Submission and assessment of all the data by the regulator typically takes:

Question Title

* 6. What are your expectations of a licensed drug? Read all the alternatives and tick all those that reflect your views

Question Title

* 7. What is the biggest hold up in the production and licensing of a new drug for PD?

Question Title

* 8. Once there is a licence what most affects drug useage?

Question Title

* 9. Alternatives to current practices - how can the regulatory process best be speeded up?

Question Title

* 10. Are you aware of any regulatory systems offering earlier drug access and assessment? 

Question Title

* 11. If you answered YES to Q10, please tick any of the following you have heard of

Question Title

* 12. How do you feel about taking a drug that has not been through the full licensing approval process?

T